PL2381925T3 - Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych - Google Patents

Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych

Info

Publication number
PL2381925T3
PL2381925T3 PL09799045T PL09799045T PL2381925T3 PL 2381925 T3 PL2381925 T3 PL 2381925T3 PL 09799045 T PL09799045 T PL 09799045T PL 09799045 T PL09799045 T PL 09799045T PL 2381925 T3 PL2381925 T3 PL 2381925T3
Authority
PL
Poland
Prior art keywords
treatment
active ingredients
pharmaceutically active
human skin
essentially free
Prior art date
Application number
PL09799045T
Other languages
English (en)
Inventor
Klaus Graupe
Gerald Städtler
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40796237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2381925(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Publication of PL2381925T3 publication Critical patent/PL2381925T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL09799045T 2008-12-23 2009-12-22 Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych PL2381925T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14015208P 2008-12-23 2008-12-23
EP08022333A EP2210588B1 (en) 2008-12-23 2008-12-23 Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin

Publications (1)

Publication Number Publication Date
PL2381925T3 true PL2381925T3 (pl) 2017-09-29

Family

ID=40796237

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08022333T PL2210588T3 (pl) 2008-12-23 2008-12-23 Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych
PL09799045T PL2381925T3 (pl) 2008-12-23 2009-12-22 Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL08022333T PL2210588T3 (pl) 2008-12-23 2008-12-23 Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych

Country Status (33)

Country Link
US (2) US8658138B2 (pl)
EP (2) EP2210588B1 (pl)
JP (2) JP5795261B2 (pl)
KR (1) KR20110103972A (pl)
CN (1) CN102325522B (pl)
AR (1) AR074839A1 (pl)
AT (1) ATE500817T1 (pl)
AU (1) AU2009331845B2 (pl)
BR (1) BRPI0923589B1 (pl)
CA (1) CA2748346C (pl)
CL (1) CL2011001468A1 (pl)
CO (1) CO6390034A2 (pl)
CR (1) CR20110337A (pl)
CU (1) CU20110132A7 (pl)
DE (1) DE602008005497D1 (pl)
DK (2) DK2210588T3 (pl)
EA (1) EA021762B1 (pl)
EC (1) ECSP11011137A (pl)
ES (2) ES2364692T3 (pl)
HR (2) HRP20170865T1 (pl)
HU (1) HUE034651T2 (pl)
IL (1) IL213359A (pl)
MX (1) MX2011006381A (pl)
NZ (1) NZ593575A (pl)
PE (1) PE20120109A1 (pl)
PL (2) PL2210588T3 (pl)
PT (2) PT2210588E (pl)
SG (1) SG171948A1 (pl)
SV (1) SV2011003948A (pl)
TW (1) TW201034695A (pl)
UA (1) UA106062C2 (pl)
WO (1) WO2010072422A1 (pl)
ZA (1) ZA201104600B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
ATE500817T1 (de) * 2008-12-23 2011-03-15 Intendis Gmbh Schäumbare zusammensetzung, die im wesentlichen frei von pharmazeutisch aktiven inhaltsstoffen ist, zur behandlung der menschlichen haut
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2009348470B2 (en) * 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
FR2994386B1 (fr) * 2012-08-07 2016-06-24 Thorel Jean-Noel Inhibition de l'adhesion de micro-organismes pathogenes par un ester de saccharose et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN108938674A (zh) * 2017-05-27 2018-12-07 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗皮肤病变药物中的用途
FR3069775B1 (fr) * 2017-08-02 2020-02-14 Roquette Freres 1,4 :3,6 dianhydrohexitols pour hydrater la peau
US12144794B2 (en) 2019-03-06 2024-11-19 Isdin, S.A. Use of caprylic and capric triglycerides for the treatment of a disease or condition mediated by filaggrin or collagen deficiency

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29824538U1 (de) * 1997-08-18 2001-08-16 Neubourg, Stephanie, 48282 Emsdetten Schaum-Hautcreme
DK1014916T4 (da) * 1997-08-18 2011-09-26 Neubourg Skin Care Gmbh & Co Kg Skum-hudbeskyttelsescreme
GB9903639D0 (en) * 1999-02-17 1999-04-07 Unilever Plc Liquid cleansing composition
JP4190303B2 (ja) * 2002-02-18 2008-12-03 日本精化株式会社 カチオン性共重合体
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
MXPA06001381A (es) 2003-08-04 2006-05-19 Foamix Ltd Vehiculo de espuma que contiene un gelificante copolimerico anfifilico.
BRPI0412975A (pt) 2003-08-25 2006-10-03 Foamix Ltd espuma penetrante para uso farmacêutico
JP4722434B2 (ja) * 2004-08-31 2011-07-13 株式会社ダイゾー 発泡性エアゾール組成物
EP1888032A2 (en) * 2005-05-09 2008-02-20 Foamix Ltd. Saccharide foamable compositions
EP2029106A2 (en) * 2006-06-07 2009-03-04 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
WO2008032212A2 (en) * 2006-09-08 2008-03-20 Foamix Ltd. Colored or colorable foamable composition and foam
JP4851907B2 (ja) * 2006-10-05 2012-01-11 Ｎｅｃディスプレイソリューションズ株式会社 ポンプユニットおよびそれを用いたプロジェクタ
ATE500817T1 (de) * 2008-12-23 2011-03-15 Intendis Gmbh Schäumbare zusammensetzung, die im wesentlichen frei von pharmazeutisch aktiven inhaltsstoffen ist, zur behandlung der menschlichen haut

Also Published As

Publication number Publication date
PT2210588E (pt) 2011-06-07
EP2381925B1 (en) 2017-03-15
CN102325522B (zh) 2013-12-25
NZ593575A (en) 2013-08-30
CN102325522A (zh) 2012-01-18
HRP20170865T1 (hr) 2017-09-08
EP2381925A1 (en) 2011-11-02
IL213359A (en) 2014-09-30
CO6390034A2 (es) 2012-02-29
TW201034695A (en) 2010-10-01
US8658138B2 (en) 2014-02-25
ES2364692T3 (es) 2011-09-12
BRPI0923589A2 (pt) 2016-07-26
HK1166263A1 (en) 2012-10-26
MX2011006381A (es) 2011-09-27
DK2210588T3 (da) 2011-06-27
EA021762B1 (ru) 2015-08-31
EA201170876A1 (ru) 2012-02-28
SG171948A1 (en) 2011-07-28
JP5795261B2 (ja) 2015-10-14
US20100247449A1 (en) 2010-09-30
KR20110103972A (ko) 2011-09-21
UA106062C2 (uk) 2014-07-25
IL213359A0 (en) 2011-07-31
ECSP11011137A (es) 2011-08-31
EP2210588A1 (en) 2010-07-28
AU2009331845A1 (en) 2011-06-30
HUE034651T2 (en) 2018-02-28
CL2011001468A1 (es) 2012-02-17
BRPI0923589B1 (pt) 2019-04-24
PL2210588T3 (pl) 2011-09-30
CA2748346A1 (en) 2010-07-01
US20140190854A1 (en) 2014-07-10
DE602008005497D1 (de) 2011-04-21
CA2748346C (en) 2017-08-22
ATE500817T1 (de) 2011-03-15
US8986658B2 (en) 2015-03-24
AR074839A1 (es) 2011-02-16
SV2011003948A (es) 2011-12-06
EP2210588B1 (en) 2011-03-09
WO2010072422A1 (en) 2010-07-01
CU20110132A7 (es) 2012-01-31
ES2628218T3 (es) 2017-08-02
DK2381925T3 (da) 2017-06-26
JP2015157860A (ja) 2015-09-03
AU2009331845B2 (en) 2015-11-12
PE20120109A1 (es) 2012-02-08
HRP20110429T1 (hr) 2011-08-31
PT2381925T (pt) 2017-06-23
ZA201104600B (en) 2022-03-30
CR20110337A (es) 2011-12-28
JP2012513430A (ja) 2012-06-14

Similar Documents

Publication Publication Date Title
ZA201104600B (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
ZA201200017B (en) Formulations for the treatment of deeep tissue pain
ZA201104079B (en) Therapeutic,dietary,or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3,and compositions containing these compounds
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
EP2063902A4 (en) THERAPEUTIC CELL MEDICAMENT WITH STEM CELLS OF SKIN
IL215831A (en) A drug containing allopurinol for use in the treatment of hand-foot skin reaction
IL213703A (en) Compounds for the treatment of pain and other diseases
PL2640364T3 (pl) Kompozycja farmaceutyczna zawierająca sól wodorowęglanową i jej zastosowanie jako leku w leczeniu i/lub profilaktyce kamicy moczowej i chorób pokrewnych
IL215460A (en) Use of vip-containing compositions for the manufacture of medications for the prevention or treatment of osteoporosis and diarrhea
ZA201004644B (en) "derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides,preparation thereof and therapeutic application thereof"
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
PL2424602T3 (pl) System do dostarczania środka leczniczego do skóry pacjenta
GB2411834B (en) Composition for use in the treatment of dry skin conditions
GB0813004D0 (en) Stable therapeutic formulation of human growth hormone
GB0616122D0 (en) Formulation for treatment of skin disorders
GB0503214D0 (en) Compositions for therapeutic treatment of skin and other conditions
GB0819037D0 (en) Skin treatment formulation
GB0716834D0 (en) New formulation for treatment of skin disorders
AU2006900256A0 (en) Skin formulation usable as a therapeutic application for the treatment of general skin disorders and a method of preparation thereof